S&P 500   4,402.20
DOW   34,440.88
QQQ   364.54
Flee to Healthcare Stocks if Recession Rears its Head?
BREAKING: Tiny biotech successfully treats blindness (Ad)
3 Tasty Dividend Stocks With Value and Above-Average Yields
3 ETFs for the Conservative Investor to Buy and Hold
The single greatest medical breakthrough of all time? (Ad)
Stock market today: World shares track Wall Street's slump after Fed says rates may stay high in '24
5 NYSE-Listed Emerging Market Stocks For Income Investors
The single greatest medical breakthrough of all time? (Ad)
Disney Denies Rumors of TV Sale, After Stock Jumps on News
Are These Consumer Staples Too Cheap for Investors To Ignore?
S&P 500   4,402.20
DOW   34,440.88
QQQ   364.54
Flee to Healthcare Stocks if Recession Rears its Head?
BREAKING: Tiny biotech successfully treats blindness (Ad)
3 Tasty Dividend Stocks With Value and Above-Average Yields
3 ETFs for the Conservative Investor to Buy and Hold
The single greatest medical breakthrough of all time? (Ad)
Stock market today: World shares track Wall Street's slump after Fed says rates may stay high in '24
5 NYSE-Listed Emerging Market Stocks For Income Investors
The single greatest medical breakthrough of all time? (Ad)
Disney Denies Rumors of TV Sale, After Stock Jumps on News
Are These Consumer Staples Too Cheap for Investors To Ignore?
S&P 500   4,402.20
DOW   34,440.88
QQQ   364.54
Flee to Healthcare Stocks if Recession Rears its Head?
BREAKING: Tiny biotech successfully treats blindness (Ad)
3 Tasty Dividend Stocks With Value and Above-Average Yields
3 ETFs for the Conservative Investor to Buy and Hold
The single greatest medical breakthrough of all time? (Ad)
Stock market today: World shares track Wall Street's slump after Fed says rates may stay high in '24
5 NYSE-Listed Emerging Market Stocks For Income Investors
The single greatest medical breakthrough of all time? (Ad)
Disney Denies Rumors of TV Sale, After Stock Jumps on News
Are These Consumer Staples Too Cheap for Investors To Ignore?
S&P 500   4,402.20
DOW   34,440.88
QQQ   364.54
Flee to Healthcare Stocks if Recession Rears its Head?
BREAKING: Tiny biotech successfully treats blindness (Ad)
3 Tasty Dividend Stocks With Value and Above-Average Yields
3 ETFs for the Conservative Investor to Buy and Hold
The single greatest medical breakthrough of all time? (Ad)
Stock market today: World shares track Wall Street's slump after Fed says rates may stay high in '24
5 NYSE-Listed Emerging Market Stocks For Income Investors
The single greatest medical breakthrough of all time? (Ad)
Disney Denies Rumors of TV Sale, After Stock Jumps on News
Are These Consumer Staples Too Cheap for Investors To Ignore?
OTCMKTS:CSLLY

CSL (CSLLY) Stock Forecast, Price & News

$84.89
-0.47 (-0.55%)
(As of 09/20/2023 ET)
Compare
Today's Range
$84.59
$87.30
50-Day Range
$84.48
$91.08
52-Week Range
$83.30
$110.25
Volume
86,567 shs
Average Volume
83,948 shs
Market Capitalization
$82.01 billion
P/E Ratio
N/A
Dividend Yield
1.40%
Price Target
N/A

CSL MarketRank™ Forecast

Analyst Rating
N/A
Upside/​Downside
N/A
Short Interest
Healthy
0.00% of Shares Sold Short
Dividend Strength
Weak
Based on Four Factors
Sustainability
N/A
News Sentiment
N/A
Insider Trading
N/A
Proj. Earnings Growth
27.13%
From $2.47 to $3.14 Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

1.62 out of 5 stars


CSLLY stock logo

About CSL (OTCMKTS:CSLLY) Stock

CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through CSL Behring, CSL Seqirus, and CSL Vifor segments. The CSL Behring segment offers plasma products, gene therapies, and recombinants. The CSL Seqirus segment provides influenza related products and pandemic services to governments. The CSL Vifor segment offers products in the therapeutic areas of iron deficiency and nephrology. The company also licenses CSL intellectual property. CSL Limited was founded in 1916 and is headquartered in Melbourne, Australia.

CSLLY Price History

CSLLY Stock News Headlines

[BREAKING] New "Living Missile" to Replace Nuclear Missiles
CBS News Reports: "It's an entirely new type of weapon." The New York Times Reports: "No existing defense can stop it." And one small company is building them for the Pentagon!
[BREAKING] New "Living Missile" to Replace Nuclear Missiles
CBS News Reports: "It's an entirely new type of weapon." The New York Times Reports: "No existing defense can stop it." And one small company is building them for the Pentagon!
RBC Capital Sticks to Its Hold Rating for CSL (CMXHF)
Why did the CSL share price tumble in July?
Wilsons Sticks to Their Buy Rating for CSL (CMXHF)
2023 BMW M4 CSL video review | Autoblog Garage
Jarden Remains a Buy on CSL (CMXHF)
UBS Remains a Buy on CSL (CMXHF)
See More Headlines
Receive CSLLY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for CSL and its competitors with MarketBeat's FREE daily newsletter.

CSLLY Company Calendar

Today
9/21/2023
Fiscal Year End
6/30/2024

Industry, Sector and Symbol

Industry
Pharmaceutical preparations
Sub-Industry
N/A
Sector
Medical
Current Symbol
OTCMKTS:CSLLY
Employees
30,000
Year Founded
1904

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
$10.56 billion
Cash Flow
$3.02 per share
Book Value
$15.13 per share

Miscellaneous

Free Float
N/A
Market Cap
$82.01 billion
Optionable
Not Optionable
Beta
0.64
Metaverse Stocks And Why You Can't Ignore Them Cover

Thinking about investing in Meta, Roblox, or Unity? Click the link to learn what streetwise investors need to know about the metaverse and public markets before making an investment.

Get This Free Report

Key Executives

  • Dr. Paul F. McKenzie Ph.D. (Age 57)
    MD, CEO & Exec. Director
    Comp: $2.75M
  • Ms. Joy Carolyn Linton B.Com. (Age 58)
    BComm, GAICD, Grad Dip AFI, Chief Financial Officer
    Comp: $2.05M
  • Mr. Paul R. Perreault B.A. (Age 66)
    Strategic Advisor
    Comp: $2.89M
  • Mr. Mark Dehring
    Head of Investor Relations
  • Mr. Gregory Boss B.S. (Age 62)
    BS(Hons), J.D., Exec. VP of Legal & Group Gen. Counsel
  • Christina Hickie
    Sr. Mang. of Communications
  • Ms. Elizabeth Walker B.A. (Age 53)
    M.S., Exec. VP & Chief HR Officer
  • Dr. Karen Etchberger (Age 65)
    Exec. VP of Quality & Bus. Services
  • Ms. Jemimah Brennan
    Head of Communications - Asia Pacific
  • Mr. William Campbell B.S. (Age 63)
    Exec. VP & Chief Commercial Officer













CSLLY Stock - Frequently Asked Questions

Should I buy or sell CSL stock right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for CSL in the last twelve months. There are currently 2 buy ratings for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" CSLLY shares.
View CSLLY analyst ratings
or view top-rated stocks.

How have CSLLY shares performed in 2023?

CSL's stock was trading at $97.54 at the start of the year. Since then, CSLLY stock has decreased by 13.0% and is now trading at $84.89.
View the best growth stocks for 2023 here
.

Are investors shorting CSL?

CSL saw a increase in short interest in August. As of August 31st, there was short interest totaling 3,100 shares, an increase of 40.9% from the August 15th total of 2,200 shares. Based on an average daily trading volume, of 140,500 shares, the days-to-cover ratio is currently 0.0 days.
View CSL's Short Interest
.

Is CSL a good dividend stock?

CSL (OTCMKTS:CSLLY) pays an annual dividend of $1.19 per share and currently has a dividend yield of 1.39%.
Read our dividend analysis for CSLLY.

What is CSL's stock symbol?

CSL trades on the OTCMKTS under the ticker symbol "CSLLY."

How do I buy shares of CSL?

Shares of CSLLY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is CSL's stock price today?

One share of CSLLY stock can currently be purchased for approximately $84.89.

How much money does CSL make?

CSL (OTCMKTS:CSLLY) has a market capitalization of $82.01 billion and generates $10.56 billion in revenue each year.

How many employees does CSL have?

The company employs 30,000 workers across the globe.

How can I contact CSL?

CSL's mailing address is 45 Poplar Road, Parkville C3, 3052. The official website for the company is www.csl.com.au. The company can be reached via phone at (139) 389-1911, via email at bernard.ronchi@csl.com, or via fax at 61-3-9389-1434.

This page (OTCMKTS:CSLLY) was last updated on 9/21/2023 by MarketBeat.com Staff

My Account -